^
+ Follow PASCUAL LABORATORIES AND PHAREX Tag
Array
(
    [results] => Array
        (
            [0] => Array
                (
                    [ArticleID] => 496283
                    [Title] => Small pharma firms not happy with Maximum Drug Retail Price
                    [Summary] => 

The implementation of the Maximum Drug Retail Price (MDRP) provision of the Cheaper Medicines Act may have the unexpected consequences of once again favoring multinational pharmaceutical companies and squeezing the smaller domestic pharma firms.

[DatePublished] => 2009-08-17 00:00:00 [ColumnID] => 133272 [Focus] => 0 [AuthorID] => 1805266 [AuthorName] => Marianne V. Go [SectionName] => Business [SectionUrl] => business [URL] => ) [1] => Array ( [ArticleID] => 458302 [Title] => Pascual Laboratories eyes P4-billion sales for this year [Summary] =>

Pascual Laboratories, Inc. expects to post P4 billion in sales this year, while its wholly-owned subsidiary Pharex Health Corp. is expecting an equally robust sales of P1.5 billion, company chairman Abrahan F. Pascual said.

[DatePublished] => 2009-04-18 00:00:00 [ColumnID] => 133272 [Focus] => 0 [AuthorID] => 1805266 [AuthorName] => Marianne V. Go [SectionName] => Business [SectionUrl] => business [URL] => ) ) )
PASCUAL LABORATORIES AND PHAREX
Array
(
    [results] => Array
        (
            [0] => Array
                (
                    [ArticleID] => 496283
                    [Title] => Small pharma firms not happy with Maximum Drug Retail Price
                    [Summary] => 

The implementation of the Maximum Drug Retail Price (MDRP) provision of the Cheaper Medicines Act may have the unexpected consequences of once again favoring multinational pharmaceutical companies and squeezing the smaller domestic pharma firms.

[DatePublished] => 2009-08-17 00:00:00 [ColumnID] => 133272 [Focus] => 0 [AuthorID] => 1805266 [AuthorName] => Marianne V. Go [SectionName] => Business [SectionUrl] => business [URL] => ) [1] => Array ( [ArticleID] => 458302 [Title] => Pascual Laboratories eyes P4-billion sales for this year [Summary] =>

Pascual Laboratories, Inc. expects to post P4 billion in sales this year, while its wholly-owned subsidiary Pharex Health Corp. is expecting an equally robust sales of P1.5 billion, company chairman Abrahan F. Pascual said.

[DatePublished] => 2009-04-18 00:00:00 [ColumnID] => 133272 [Focus] => 0 [AuthorID] => 1805266 [AuthorName] => Marianne V. Go [SectionName] => Business [SectionUrl] => business [URL] => ) ) )
abtest
Are you sure you want to log out?
X
Login

Philstar.com is one of the most vibrant, opinionated, discerning communities of readers on cyberspace. With your meaningful insights, help shape the stories that can shape the country. Sign up now!

Get Updated:

Signup for the News Round now

FORGOT PASSWORD?
SIGN IN
or sign in with